Monoaminergic Antidepressants in the Relief of Pain: Potential Therapeutic Utility of Triple Reuptake Inhibitors (TRIs)

Author： Hache Guillaume   Coudore François   Gardier Alain M.   Guiard Bruno P.  

Publisher： MDPI

E-ISSN： 1424-8247|4|2|285-342

ISSN： 1424-8247

Source： Pharmaceuticals, Vol.4, Iss.2, 2011-01, pp. : 285-342

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Potential Role of Nanotechnology in Therapeutic Approaches for Triple Negative Breast Cancer

By Johnson Rebecca   Sabnis Nirupama   McConathy Walter J.   Lacko Andras G.  

Pharmaceutics, Vol. 5, Iss. 2, 2013-06 ,pp. : 353-370

MDPI

Access to resources Recommend Favorite

Nitric Oxide Synthase Inhibitors as Antidepressants

By Wegener Gregers   Volke Vallo  

Pharmaceuticals, Vol. 3, Iss. 1, 2010-01 ,pp. : 273-299

MDPI

Access to resources Recommend Favorite

Resiniferatoxin: The Evolution of the “Molecular Scalpel” for Chronic Pain Relief

By Brown Dorothy Cimino  

Pharmaceuticals, Vol. 9, Iss. 3, 2016-08 ,pp. : 47-47

MDPI

Access to resources Recommend Favorite

Tetrodotoxin (TTX) as a Therapeutic Agent for Pain

By Nieto Francisco Rafael   Cobos Enrique José   Tejada Miguel Ángel   Sánchez-Fernández Cristina   González-Cano Rafael   Cendán Cruz Miguel  

Marine Drugs, Vol. 10, Iss. 2, 2012-01 ,pp. : 281-305

MDPI

Access to resources Recommend Favorite

Conotoxins: Therapeutic Potential and Application

By Layer Richard T.   McIntosh J. Michael  

Marine Drugs, Vol. 4, Iss. 3, 2006-04 ,pp. : 119-142

MDPI

Access to resources Recommend Favorite